osimertinib
astrazeneca
['osimertinib', 'ferring']
 absolutely not. in fact, with the pattern that dfs begins to drop off immediately after treatment ends, the available evidence would indicate that osimertinib is not curing these patients but rather deferring relapses.
Med Onc,@CityofHope; VP Netwk Strategy AccessHope, Founder,@CancerGRACE; Web Ed,@JAMAOnc; Author/Ed, @UptoDate

Telemed/digital med fan. 
Disclosures @ website